BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• FDA

  FDA Approves Kowa Pharmaceuticals America’s LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

  August 4, 2009

   · 

  5 min read
• FDA

  CryoLife, Inc. Receives CE Mark Approval for BioFoam(R) Hemostatic Technology

  August 4, 2009

   · 

  4 min read
• Probe Scientific Raises £1 Million

  August 4, 2009

   · 

  1 min read
• Job Trends

  Saline Lectronics Secures State Financing, Diversifies into Aeronautics and Medical Device Industries; Plans to Add 53 Jobs

  August 4, 2009

   · 

  1 min read
• BioMidwest

  Freedom Meditech, Inc. Secures Second Tranche of Series A Financing

  August 4, 2009

   · 

  3 min read
• FDA

  Elan Drug Technologies Announces First Approval of a Long Acting Injectable Formulation Using NanoCrystal(R) Technology

  August 4, 2009

   · 

  3 min read
• Policy

  Data Conversion Laboratory Supports Newest SPL Requirements For Life Sciences Industry

  August 4, 2009

   · 

  1 min read
• Deals

  La Jolla Pharmaceutical Company Plans Liquidation

  August 4, 2009

   · 

  1 min read
• Deals

  Adaltis Inc. Files for Bankruptcy in Canada

  August 4, 2009

   · 

  3 min read
• Business

  Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930 A First-in-Class, Small Molecule Activator of AMPK for Treatment of Type 2 Diabetes

  August 4, 2009

   · 

  4 min read